These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Noninvasive tools to assess liver disease. Clark PJ; Patel K Curr Opin Gastroenterol; 2011 May; 27(3):210-6. PubMed ID: 21248634 [TBL] [Abstract][Full Text] [Related]
8. New diagnostic method for liver fibrosis and cirrhosis. Han KH; Yoon KT Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943 [TBL] [Abstract][Full Text] [Related]
9. Assessment of fibrosis in chronic liver diseases. Zhou K; Lu LG J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541 [TBL] [Abstract][Full Text] [Related]
10. Proteomic approaches in the search for biomarkers of liver fibrosis. Cowan ML; Rahman TM; Krishna S Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704 [TBL] [Abstract][Full Text] [Related]
11. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Adams LA; Angulo P Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Thuluvath PJ; Krok KL Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552 [TBL] [Abstract][Full Text] [Related]
13. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C. Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364 [TBL] [Abstract][Full Text] [Related]
14. A clinical and histopathologic perspective on evolving noninvasive and invasive alternatives for liver biopsy. Van Leeuwen DJ; Balabaud C; Crawford JM; Bioulac-Sage P; Dhillon AP Clin Gastroenterol Hepatol; 2008 May; 6(5):491-6. PubMed ID: 18455694 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083 [TBL] [Abstract][Full Text] [Related]
17. [Clinical application of non-invasive diagnosis for hepatic fibrosis]. Cho SW; Cheong JY Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive monitoring of patients with chronic hepatitis C. Fontana RJ; Lok AS Hepatology; 2002 Nov; 36(5 Suppl 1):S57-64. PubMed ID: 12407577 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease]. Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264 [TBL] [Abstract][Full Text] [Related]
20. FibroMAX: towards a new universal biomarker of liver disease? Morra R; Munteanu M; Imbert-Bismut F; Messous D; Ratziu V; Poynard T Expert Rev Mol Diagn; 2007 Sep; 7(5):481-90. PubMed ID: 17892356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]